Influence
April 1, 2025

Medicare Beneficiary Receipt of Methadone by Drive Time to Opioid Treatment Programs

Kosali Simon, PhD

Published in JAMA Network Open. Here is a link to the article.

Regenstrief Institute authors: Kosali Simon, PhD, M.A.

This study examined how proximity to opioid treatment programs (OTPs) impacts methadone receipt among Medicare beneficiaries diagnosed with opioid use disorder (OUD) in 2020. Using Medicare claims and drive-time data, researchers found that methadone receipt decreased as distance to an OTP increased. Urban beneficiaries living within 5 minutes of an OTP were 54% more likely to receive methadone than those 15 minutes away; in rural areas, the drop was 27%. A threshold effect was observed at a 20-minute drive time, beyond which the likelihood of methadone receipt leveled off and showed minimal differences between urban and rural populations. The findings highlight the importance of OTP location in improving access to OUD treatment.

Authors

Jonathan Cantor 1, Helin G Hernandez 1, Aaron Kofner 2, Julie Lai 1, Denis Agniel 1, Kosali I Simon 3, Bradley D Stein 4, Erin A Taylor 1

Affiliations

1RAND, Santa Monica, California.

2RAND, Arlington, Virginia.

3O’Neill School of Public and Environmental Affairs, Indiana University, Bloomington.

4RAND, Pittsburgh, Pennsylvania.

Related News

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher

Rachel Patzer, PhD, MPH

Building trust in healthcare AI through data and evidence

As artificial intelligence rapidly transforms healthcare, innovation alone is not enough. Health systems need evidence that AI tools are

doctor using electronic health record

Data expertise helps researchers understand how clinical tools are used in real-world care

Regenstrief Data Services (RDS) provided critical health data and specialized expertise to support research examining clinical decision-support use across